Received Mar 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 54RR9 | — |
lump in arm under site; pain; This non-serious case was reported by a other health professional via other manufacturer and described the occurrence of injection site lump in a 19-year-old female patient who received Men B NVS (Bexsero) (batch number 54RR9) for prophylaxis. On 09-FEB-2026, the patient received Bexsero. In FEB-2026, an unknown time after receiving Bexsero, the patient experienced injection site lump (Verbatim: lump in arm under site) and pain (Verbatim: pain). The outcome of the injection site lump and pain were not reported. It was unknown if the reporter considered the injection site lump and pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the injection site lump and pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date 05-MAR-2026 The reporter did not consent to follow up.